HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1: A Drug Target / Disease Biomarker

Target Name: HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1

NCBI ID: G105369230

HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1: A Drug Target / Disease Biomarker

HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1 is a protein that is expressed in the major histocompatibility complex (MHC) class II molecules. It is a key component of the immune system and plays a crucial role in the regulation of T cell development and function. DRB1-7 beta chain, transcript variant X1 is a specific variant of the DRB1 gene that is located on the X chromosome.

The DRB1 gene is a member of the major histocompatibility complex (MHC) class II gene family. These genes encode antigens that are recognized by T cells as foreign and activate an immune response. The MHC class II system is one of the four main systems used by the immune system to recognize and respond to foreign antigens.

DRB1-7 beta chain is a transmembrane protein that is expressed in various tissues and cells of the body. It is a key component of the immune system and plays a crucial role in the regulation of T cell development and function. The DRB1-7 gene is located on the X chromosome and has four exons.

Transcript variant X1 is a specific variant of the DRB1 gene that is located on the X chromosome. It is a single-exon gene that encodes a protein with 114 amino acid residues. The protein has a unique structure and is expressed in various tissues and cells of the body.

HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1 is a protein that is expressed in the immune system and plays a crucial role in the regulation of T cell development and function. It is a potential drug target or biomarker and may be used in the development of new therapies for various diseases.

Protein Name: HLA Class II Histocompatibility Antigen, DRB1-7 Beta Chain, Transcript Variant X1

More Common Targets